期刊
LANCET INFECTIOUS DISEASES
卷 14, 期 11, 页码 1113-1122出版社
ELSEVIER SCI LTD
DOI: 10.1016/S1473-3099(14)70831-X
关键词
-
资金
- European Developing Countries Clinical trials Partnership (EDCTP), UBS Optimus Foundation, Switzerland
- NIHR Biomedical Research Centre, University College London Hospital, London, UK
The past decade has seen the emergence of several novel viruses that cause respiratory tract infections in human beings, including Middle East respiratory syndrome coronavirus (MERS-CoV) in Saudi Arabia, an H7N9 influenza A virus in eastern China, a swine-like influenza H3N2 variant virus in the USA, and a human adenovirus 14p1 also in the USA. MERS-CoV and H7N9 viruses are still a major worldwide public health concern. The pathogenesis and mode of transmission of MERS-CoV and H7N9 influenza A virus are poorly understood, making it more difficult to implement intervention and preventive measures. A united and coordinated global response is needed to tackle emerging viruses that can cause fatal respiratory tract infections and to fill major gaps in the understanding of the epidemiology and transmission dynamics of these viruses.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据